Cancer centre sues BMS and Ono over alleged patent exploitation
25-06-2019
360b / Shutterstock.com
Bristol-Myers Squibb (BMS) has accused pharmaceutical company Merck of infringing a patent covering a method used to treat cancer.
You need a subscription to continue reading this content.
Start a subscription today to access the LSIPR website.
To access the full archive, digital magazines and special reports you will need to take out a paid subscription.
If you have already subscribed please login.
If you have any technical issues please email tech support.
For access to the complete website, archive, and to receive print publications, choose '12 MONTH SUBSCRIPTION'. For a free, two-week trial with full access, select ‘TWO WEEK FREE TRIAL’.
Bristol-Myers Squibb, Merck, Patent, Keytruda
